Eleven Biotherapeutics Inc. (EBIO) rose 11.51% or 0.34 to $3.25. It is near 6.45 million shares traded, which is 140.46% compare to the average total volume 4.59 million. The market cap of EBIO is $139.88 million. The year to date change is 250.6%. The 52 week price range is from $0.62 to $3.25. Price of EBIO have changed 22.78% during last week. It have changed 179.81% over last month, 179.81% over last 3 months, 187.81% over last 6 months and 53.16% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for EBIO is 1.33. It is -59.08% below current price. The 200-day Moving Averages for EBIO is 1.15. It is -64.62% below current price. The 52-week High is 3.25. The stock hits 52-week high today. The 52-week Low is 0.62. It is -80.92% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of EBIO is 0.46 on 2018-04-13. Short % to float is 2.96%. There are some statistics of EBIO. It is has market cap $139.88 million. The share outstanding is 43.11 million. The average volume is 4.59 million. The revenue is 425000. The percent of top 15 Institution holding is 15.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of EBIO is -102.38%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of EBIO is -32.40%.